[ibimage==38399==Original==none==self==ibimage_align-center]
NantHealth has big plans on the horizon.
The Culver City-based science and tech healthcare platform has received $200 million from Allscripts, who will now hold a 10 percent stake in the company.
The investment will reportedly pave the way for NantHealth to go public by the end of the year.
NantHealth and Allscripts will cooperate as they continue to develop their molecular diagnostics technology aimed at profiling cancer cells in patients with a genetic history of cancer. The Genomic Proteomic Sequencing diagnostics test creates personalized cancer treatment plans for these patients, creating a streamlined process for performing clinical trials, monitoring outcomes, and controlling cost in real time.
In accordance with the investment, Dr. Patrick Soon-Shiong’s personal investment group, NantCapital, made a $100 million investment into Allscripts.
Have a tip for us or know of a company that deserves coverage? Email us via [email protected]
